Literature DB >> 29725790

Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594.

Katya Corado1, Sonia Jain2, Sheldon Morris2, Michael P Dube3, Eric S Daar4, Feng He2, Jeannette L Aldous5, Amy Sitapati6, Richard Haubrich7, Joel Milam8, Maile Young Karris6.   

Abstract

Poor linkage, engagement and retention remain significant barriers in achieving HIV treatment goals in the US. HIV-infected persons entering or re-entering care across three Southern California academic HIV clinics, were randomized (1:1) to an Active, Linkage, Engagement, Retention and Treatment (ALERT) specialist for outreach and health coaching, or standard of care (SOC). The primary outcome of time to loss to follow up (LTFU) was compared using Cox proportional hazards regression modeling. No differences in the median time to LTFU (81.7 for ALERT versus 93.6 weeks for SOC; HR 1.27; p = 0.40), or time to ART initiation was observed (N = 116). Although, ALERT participants demonstrated worsening depressive symptomatology from baseline to week 48 compared to SOC (p = 0.02). The ALERT intervention did not improve engagement and retention in HIV care over SOC. Further studies are needed to determine how best to apply resources to improve retention and engagement.

Entities:  

Keywords:  Adherence; CCTG 594; HIV engagement in care; Health coaching; Lost to Follow up

Mesh:

Year:  2018        PMID: 29725790      PMCID: PMC6599592          DOI: 10.1007/s10461-018-2132-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  59 in total

1.  The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people.

Authors:  L Gelberg; R M Andersen; B D Leake
Journal:  Health Serv Res       Date:  2000-02       Impact factor: 3.402

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

3.  Development and psychometric evaluation of the brief HIV Knowledge Questionnaire.

Authors:  Michael P Carey; Kerstin E E Schroder
Journal:  AIDS Educ Prev       Date:  2002-04

4.  Factors influencing knowledge of and adherence to self-care among patients with heart failure.

Authors:  H Ni; D Nauman; D Burgess; K Wise; K Crispell; R E Hershberger
Journal:  Arch Intern Med       Date:  1999-07-26

5.  Adherence to combination antiretroviral therapies in HIV patients of low health literacy.

Authors:  S C Kalichman; B Ramachandran; S Catz
Journal:  J Gen Intern Med       Date:  1999-05       Impact factor: 5.128

6.  Health literacy and health-related knowledge among persons living with HIV/AIDS.

Authors:  S C Kalichman; E Benotsch; T Suarez; S Catz; J Miller; D Rompa
Journal:  Am J Prev Med       Date:  2000-05       Impact factor: 5.043

7.  HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa.

Authors:  S C Kalichman; L C Simbayi
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

8.  Diagnosis and reporting of HIV and AIDS in states with HIV/AIDS surveillance--United States, 1994-2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-07-12       Impact factor: 17.586

9.  Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /l.

Authors:  Milos Opravil; Bruno Ledergerber; Hansjakob Furrer; Bernard Hirschel; Alexander Imhof; Serge Gallant; Thomas Wagels; Enos Bernasconi; Fabian Meienberg; Martin Rickenbach; Rainer Weber
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

10.  Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.

Authors:  Anita Palepu; Nicholas J Horton; Nicole Tibbetts; Seville Meli; Jeffrey H Samet
Journal:  Addiction       Date:  2004-03       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.